Company Name: Medgenics, Inc.
Medgenics, Inc. is a clinical stage orphan and rare disease company. The company’s proprietary Transduced Autologous Restorative Gene Therapy (TARGT) ex vivo gene therapy platform is designed to treat a variety of rare diseases/conditions through sustained protein and peptide therapies. The company’s lead product candidate is designed to treat End Stage Renal Disease.
Ticker Symbol: MDGN (NASDAQ)
Company Website: www.medgenics.com
Social Media: Medgenics LinkedIn
Headquarters: Wayne, PA